Rep. Debbie Wasserman Schultz Purchases Shares of Baxter International Inc. (NYSE:BAX)

Representative Debbie Wasserman Schultz (D-Florida) recently bought shares of Baxter International Inc. NYSE: BAX. In a filing disclosed on November 20th, the Representative disclosed that they had bought between $1,001 and $15,000 in Baxter International stock on November 18th.

Representative Debbie Wasserman Schultz also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of New Gold NYSE: NGD on 11/18/2024.
• Purchased $1,001 - $15,000 in shares of Patterson-UTI Energy NASDAQ: PTEN on 10/23/2024.
• Purchased $1,001 - $15,000 in shares of Viasat NASDAQ: VSAT on 10/23/2024.

Baxter International Trading Up 0.7 %

NYSE:BAX traded up $0.22 during trading hours on Friday, hitting $33.21. 4,640,657 shares of the company were exchanged, compared to its average volume of 4,107,361. The stock has a market capitalization of $16.96 billion, a price-to-earnings ratio of 165.61, a price-to-earnings-growth ratio of 12.91 and a beta of 0.60. The company has a current ratio of 1.43, a quick ratio of 1.09 and a debt-to-equity ratio of 1.31. Baxter International Inc. has a one year low of $31.60 and a one year high of $44.01. The company has a fifty day simple moving average of $36.34 and a 200 day simple moving average of $35.69.

Baxter International (NYSE:BAX - Get Free Report) last issued its quarterly earnings results on Friday, November 8th. The medical instruments supplier reported $0.80 earnings per share for the quarter, topping analysts' consensus estimates of $0.78 by $0.02. Baxter International had a return on equity of 18.30% and a net margin of 0.77%. The firm had revenue of $3.85 billion during the quarter, compared to the consensus estimate of $3.85 billion. During the same period last year, the business posted $0.68 EPS. The business's revenue was up 3.8% compared to the same quarter last year. Sell-side analysts expect that Baxter International Inc. will post 1.98 EPS for the current fiscal year.

Baxter International Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 2.05%. The ex-dividend date of this dividend is Friday, November 29th. Baxter International's dividend payout ratio is currently 580.03%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. JPMorgan Chase & Co. decreased their price target on Baxter International from $44.00 to $42.00 and set a "neutral" rating for the company in a report on Wednesday, August 7th. Citigroup increased their price target on Baxter International from $38.00 to $40.00 and gave the stock a "neutral" rating in a report on Tuesday, October 1st. The Goldman Sachs Group raised their target price on Baxter International from $36.00 to $40.00 and gave the company a "neutral" rating in a research note on Thursday, August 8th. Wells Fargo & Company reduced their target price on Baxter International from $44.00 to $40.00 and set an "equal weight" rating for the company in a research note on Wednesday, August 7th. Finally, Stifel Nicolaus reduced their target price on Baxter International from $46.00 to $38.00 and set a "buy" rating for the company in a research note on Monday, November 11th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Baxter International has an average rating of "Hold" and a consensus target price of $40.91.

Hedge Funds Weigh In On Baxter International

A number of hedge funds have recently added to or reduced their stakes in the stock. LSV Asset Management bought a new position in shares of Baxter International during the 2nd quarter worth approximately $140,296,000. Bank of New York Mellon Corp lifted its position in shares of Baxter International by 73.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 6,772,533 shares of the medical instruments supplier's stock worth $226,541,000 after buying an additional 2,862,626 shares in the last quarter. Thompson Siegel & Walmsley LLC bought a new stake in shares of Baxter International in the 2nd quarter worth approximately $67,263,000. Coho Partners Ltd. bought a new stake in shares of Baxter International in the 3rd quarter worth approximately $57,229,000. Finally, Shapiro Capital Management LLC raised its holdings in shares of Baxter International by 19.7% in the 2nd quarter. Shapiro Capital Management LLC now owns 3,285,048 shares of the medical instruments supplier's stock worth $109,885,000 after purchasing an additional 541,575 shares during the period. Institutional investors and hedge funds own 90.19% of the company's stock.

About Representative Wasserman Schultz

Debbie Wasserman Schultz (Democratic Party) is a member of the U.S. House, representing Florida's 25th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2025. Wasserman Schultz (Democratic Party) is running for re-election to the U.S. House to represent Florida's 25th Congressional District. She declared candidacy for the Democratic primary scheduled on August 20, 2024. Wasserman Schultz was first elected to the U.S. House in 2004 from District 20. She previously represented District 34 of the Florida State Senate from 2003 to 2004, District 32 of the Florida State Senate from 2001 to 2003, and District 97 of the Florida House of Representatives from 1993 to 2001. She served as one of the Chief Deputy Whips of the Democratic caucus for the 113th Congress. She also served as the chair of the Democratic National Committee. On July 24, 2016, Wasserman Schultz announced that she would resign her leadership position at the end of the party's convention. Wasserman Schultz was considered a possible candidate in 2016 for U.S. Senate. However, she announced on March 17, 2015, that she would not seek the Senate seat and would instead run for re-election to the House. Debbie Wasserman Schultz was born in Forest Hills, New York. Wasserman Schultz graduated from Half Hollow Hills High School East in 1984. She earned a B.A. and M.A. from the University of Florida in 1988 and 1990, respectively. Wasserman Schultz's career experience includes working as a staffer to former U.S. Representative Peter Deutsch.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.